These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
130 related articles for article (PubMed ID: 18869790)
1. Present status of the poison ivy problem. MASON HS Ind Hyg Newsl; 1948 Jul; 8(7):5. PubMed ID: 18869790 [No Abstract] [Full Text] [Related]
2. A clinical evaluation of the prophylactic treatment of poison ivy dermatitis with an alum-precipitated pyridine extract of Rhus toxicodendron. PASSENGER RE J Allergy; 1963; 34():270-4. PubMed ID: 13941710 [No Abstract] [Full Text] [Related]
3. Poison ivy (Rhus toxicodendron); a survey of the poison ivy problem in Canada and some independent observations on the value of zirconium products in prophylaxis and treatment. CASPERS AP Can Med Assoc J; 1957 May; 76(10):852-60. PubMed ID: 13426931 [No Abstract] [Full Text] [Related]
4. Poison ivy (Rhus) dermatitis; an experimental study. KLIGMAN AM AMA Arch Derm; 1958 Feb; 77(2):149-80. PubMed ID: 13497290 [No Abstract] [Full Text] [Related]
6. Evaluation of intramuscular injections of specific extracts in the treatment of acute poison ivy dermatitis. HOWELL JB Ann Allergy; 1947; 5(3):219-23. PubMed ID: 20242273 [No Abstract] [Full Text] [Related]
7. NEW and nonofficial remedies: poison ivy-poison oak extract combined. J Am Med Assoc; 1950 Jul; 143(9):813. PubMed ID: 15421829 [No Abstract] [Full Text] [Related]
8. A quantitative study of the relation of synthetic 3-pentadecyl catechol to hypersensitiveness to Rhus toxicodendron (poison ivy) as shown by the patch test. KEIL H; WASSERMAN D; DAWSON CR J Allergy; 1945; 16():275-9. PubMed ID: 21006656 [No Abstract] [Full Text] [Related]
9. ATTEMPTS TO HYPOSENSITIZE WITH POISON IVY EXTRACTS. KANOF NB; BAER RL Ann Allergy; 1964 Apr; 22():161-4. PubMed ID: 14145236 [No Abstract] [Full Text] [Related]
13. The oxidative inactivation of poison ivy irritants and related phenolic derivatives by laccase. SIZER IW; LOGEMANN ED Anat Rec; 1946 Mar; 94():429. PubMed ID: 21020562 [No Abstract] [Full Text] [Related]
14. Newer concepts and developments concerning poison ivy and allied conditions. PROKESCH CE Arch Pediatr (N Y); 1950 Jun; 67(6):267-79. PubMed ID: 15426524 [No Abstract] [Full Text] [Related]
15. The biological assay of poison ivy extract. DUNN JE; SMITH BS J Invest Dermatol; 1946 Aug; 7(4):185-99. PubMed ID: 20244423 [No Abstract] [Full Text] [Related]
16. The chemistry of poison ivy. DAWSON CR Trans N Y Acad Sci; 1956 Mar; 18(5):427-43. PubMed ID: 13312069 [No Abstract] [Full Text] [Related]
17. The oxidation and inactivation of poison ivy irritants and other phenolic derivatives by peroxidase and hydrogen peroxide. SIZER IW Anat Rec; 1946 Mar; 94():429. PubMed ID: 21066200 [No Abstract] [Full Text] [Related]
18. ON THE ISOLATION OF THE ALLERGENICALLY ACTIVE COMPONENTS OF THE TOXIC PRINCIPLE OF POISON IVY. MARKIEWITZ KH; DAWSON CR J Org Chem; 1965 May; 30():1610-3. PubMed ID: 14290380 [No Abstract] [Full Text] [Related]
19. Poison ivy; a summary of 100 cases treated with aqueous, alum precipitated pyridine, extract. GAILLARD GE J Allergy; 1950 Jan; 21(1):55-62. PubMed ID: 15400299 [No Abstract] [Full Text] [Related]
20. AN ASSAY FOR PENTADECYLCATECHOLS IN POISON IVY EXTRACTS BY GAS CHROMATOGRAPHY. SRINIVASAN S; BAER H; BOWSER R; KARMEN A Anal Biochem; 1963 Sep; 6():234-9. PubMed ID: 14065922 [No Abstract] [Full Text] [Related] [Next] [New Search]